Aminex Therapeutics, Inc.
4 clinical trials · Sponsor
◉ Watch Aminex Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors (NCT07287917) | Aminex Therapeutics, Inc. | 2026-01-26 |
| Oral AMXT 1501 Dicaprate in Combination With IV DFMO (NCT05500508) | Aminex Therapeutics, Inc. | 2022-11-29 |
| Study of Orally-Administered AMXT 1501 Dicaprate in Normal Healthy Volunteers (NCT03077477) | Aminex Therapeutics, Inc. | 2018-06-12 |
| Oral AMXT 1501 Dicaprate in Combination With DFMO (NCT03536728) | Aminex Therapeutics, Inc. | 2018-06-12 |
Track Aminex Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.